AAAAAA
Results:
1-12
|
Results: 12
Authors:
Quaedvlieg, PFHJ
Visser, O
Lamers, CBHW
Janssen-Heijen, MLG
Taal, BG
Citation: Pfhj. Quaedvlieg et al., Epidemiology and survival in patients with carcinoid disease in the Netherlands - An epidemiological study with 2391 patients, ANN ONCOL, 12(9), 2001, pp. 1295-1300
Authors:
Vasen, HFA
Stormorken, A
Menko, FH
Nagengast, FM
Kleibeuker, JH
Griffioen, G
Taal, BG
Moller, P
Wijnen, JT
Citation: Hfa. Vasen et al., MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families, J CL ONCOL, 19(20), 2001, pp. 4074-4080
Authors:
Westermann, AM
Taal, BG
Swart, M
Boot, H
Craanen, M
Gerritsen, WR
Citation: Am. Westermann et al., Sequence-dependent toxicity profile in modified FAMTX (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: A feasibility study, PHARMAC RES, 42(2), 2000, pp. 151-156
Authors:
Taal, BG
Hoefnagel, C
Boot, H
Olmos, RV
Rutgers, M
Citation: Bg. Taal et al., Improved effect of I-131-MIBG treatment by predosing with non-radiolabeledMIBG in carcinoid patients, and studies in xenografted mice, ANN ONCOL, 11(11), 2000, pp. 1437-1443
Authors:
Hoefnagel, CA
Taal, BG
Sivro, F
Boot, H
Olmos, RAV
Citation: Ca. Hoefnagel et al., Enhancement of I-131-MIBG uptake in carcinoid tumours by administration ofunlabelled MIBG, NUCL MED C, 21(8), 2000, pp. 755-761
Authors:
Van Triest, B
Loftus, BM
Pinedo, HM
Backus, HHJ
Schoenmakers, P
Telleman, F
Tadema, T
Aherne, GW
Van Groeningen, CJ
Zoetmulder, FAN
Taal, BG
Johnston, PG
Peters, GJ
Citation: B. Van Triest et al., Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody, J HIST CYTO, 48(6), 2000, pp. 755-760
Authors:
Taal, BG
Peterse, H
Boot, H
Citation: Bg. Taal et al., Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma, CANCER, 89(11), 2000, pp. 2214-2221
Authors:
Sparidans, RW
Taal, BG
Beijnen, JH
Citation: Rw. Sparidans et al., Bioanalysis of m-iodobenzylguanidine in plasma by high-performance liquid chromatography after derivatization with benzoin, J CHROMAT B, 730(2), 1999, pp. 193-199
Authors:
Zuetenhorst, H
Taal, BG
Boot, H
Olmos, RV
Hoefnagel, G
Citation: H. Zuetenhorst et al., Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBC): pharmacological MIBG, I-131-labelled MIBG and the combination, EUR J GASTR, 11(10), 1999, pp. 1157-1164
Authors:
de Jong, D
Aleman, BMP
Taal, BG
Boot, H
Citation: D. De Jong et al., Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey, ANN ONCOL, 10(3), 1999, pp. 275-280
Authors:
Taal, BG
Hoefnagel, C
Rutgers, M
Citation: Bg. Taal et al., Carcinoid tumors, N ENG J MED, 341(6), 1999, pp. 454-454
Authors:
Taal, BG
Westerman, H
Boot, H
Rankin, EM
Citation: Bg. Taal et al., Clinical and endoscopic features of melanoma metastases in the upper GI tract, GASTROIN EN, 50(2), 1999, pp. 261-263
Risultati:
1-12
|